News

BMDW: 25 Jahre Exzellenz, Innovation und Standortsicherung: Die Christian Doppler Forschungsgesellschaft feiert Jubiläum

CDG-Preis für Forschung und Innovation geht an Oskar Aszmann (MedUni Wien) und seinen Unternehmenspartner Ottobock für…

Nabriva Therapeutics Granted New Technology Add-On Payment for XENLETA® (lefamulin) and CONTEPO™ (fosfomycin) by Centers for Medicare & Medicaid Services

-NTAP designation highlights need for novel antibiotics to fight drug-resistant infections and advance antimicrobial…

aws: World IP Day Event: Schutz und Verwertung von Innovationen ist für den Standort entscheidend

Event zeigt die wirtschaftliche Bedeutung von Schutzrechten für den Innovationsstandort. Mehr als 100 ExpertInnen…

AFFiRiS announces publication in Movement Disorders Journal of positive clinical results of a Phase 1 trial in early Multiple System Atrophy

- Specific active immunotherapies (SAITs) PD01A and PD03A targeting aSyn assessed in randomised, double-blind,…

Technoclone: FIRST QUANTITATIVE SARS-CoV-2 ANTIBODY TEST

A contribution to contain the global pandemic

UpNano: HIGH RESOLUTION 3D-PRINTING: MORE LASER POWER ALLOWS FASTER PRODUCTION OF ULTRA-PRECISE POLYMERIC PARTS ACROSS 12 ORDERS OF MAGNITUDE

Use of a high-power laser enables Austrian specialist for 2PP 3D-printing to produce highly precise and fast in the…

SARS-CoV-2 Main Protease now available at EUCODIS

We are proud to announce the addition of the SARS-CoV-2 main protease (SARS-CoV-2 Mpro) to our product portfolio. The…

Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million

Valneva SE (“Valneva”), a specialty vaccine company, today announced the signing of a new contract, lasting up to three…

Auswirkungen von COVID-19 auf Diabetes-Patienten: ÖDG startet Studie mit Unterstützung von Boehringer Ingelheim

- Datenerhebung erfolgt über anonymes Register

- Diabetes-Patienten gelten als besonders vulnerabel

- Boehringer…

IMP: City of Vienna honours Meinrad Busslinger

Since 1947, the City of Vienna honours residents distinguished in a range of disciplines with the “Preis der Stadt Wien”…

Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate

Eveliqure Biotechnologies GmbH today announces the award of a US government contract from the National Institute of…

MedUni Vienna: Vitamin B1 deficiency a key factor in the development of alcohol-related dementia

A common consequence of chronically high alcohol consumption is a decline in cognitive function, which can even progress…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.